Latest Articles and Analysis

Copay accumulator programs exclude patient assistance from deductibles, creating barriers to medication adherence and treatment.

Declining vaccination rates and policy challenges create vulnerability to vaccine-preventable diseases and epidemic risk.

Convergence of influenza, avian flu, and tuberculosis threats reveals inadequate pandemic preparedness and disease response capacity.

Elimination of health equity research funding undermines evidence base for addressing healthcare disparities and structural inequalities.

Elimination of surveillance funding creates blind spots in disease tracking and health equity measurement.

Proposed Medicaid cuts and work requirements threaten coverage for millions including people living with HIV.

FTC investigation confirms pharmacy benefit managers extracted billions in excess revenue through specialty drug markup schemes.

Insurance companies deploy AI algorithms for automated prior authorization denials, restricting patient access to prescribed treatments.

Pragmatic approach to healthcare policy reform requires accepting incremental progress while maintaining advocacy commitment.

Healthcare policy opportunities and threats during lame duck congressional session.

Partisan political battles threaten essential public health programs and HIV funding.

Pugh reflects on 340B policy and patient advocacy in ensuring equitable medication access.

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.

Proposed Cigna-Humana merger implications for healthcare competition and access.

Federal policy failures on copay accumulator programs restrict patient assistance benefits.

FTC complaint against major PBMs for anticompetitive rebating and insulin pricing.

Medicaid disenrollment during pandemic unwinding and impacts on vulnerable populations.

Barriers to PrEP access for minors in Southern states: legal and political obstacles.

ADA conflicts with state prescription drug affordability board operations.

FTC enforcement against hospital mergers and implications for costs and access.